63 related articles for article (PubMed ID: 23249203)
1. Global Governance for Personalized Medicine, Politics of Uncertainty, and Pierre Bourdieu.
Özdemir V
OMICS; 2024 May; 28(5):211-212. PubMed ID: 38709543
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology in dentistry: prevention, diagnosis, and therapy.
Abou Neel EA; Bozec L; Perez RA; Kim HW; Knowles JC
Int J Nanomedicine; 2015; 10():6371-94. PubMed ID: 26504385
[TBL] [Abstract][Full Text] [Related]
3. Role and implications of nanodiagnostics in the changing trends of clinical diagnosis.
Alharbi KK; Al-Sheikh YA
Saudi J Biol Sci; 2014 Apr; 21(2):109-17. PubMed ID: 24600302
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Novel theranostic agents for precision therapeutics.
Karim S; Siddiqui NA; Khan MI; Wahajuddin M; Syed S
Front Pharmacol; 2024; 15():1407366. PubMed ID: 38694918
[No Abstract] [Full Text] [Related]
5. The Hierarchy of SUVs: From Diagnostics to Therapeutics and the Pathway to Effective Theranostics.
Hofman MS
J Nucl Med; 2023 Dec; 64(12):1845-1847. PubMed ID: 37945381
[No Abstract] [Full Text] [Related]
6. Innovation without integration.
Cohen AB; Martin SS
NPJ Digit Med; 2020; 3():15. PubMed ID: 32025575
[No Abstract] [Full Text] [Related]
7. The ethical aspects of exposome research: a systematic review.
Safarlou CW; Jongsma KR; Vermeulen R; Bredenoord AL
Exposome; 2023 Apr; 3(1):osad004. PubMed ID: 37745046
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2.
Dhar A; Gupta SL; Saini P; Sinha K; Khandelwal A; Tyagi R; Singh A; Sharma P; Jaiswal RK
Immunol Res; 2024 Feb; 72(1):14-33. PubMed ID: 37682455
[TBL] [Abstract][Full Text] [Related]
9. Ethical and legal challenges in nanomedical innovations: a scoping review.
Wasti S; Lee IH; Kim S; Lee JH; Kim H
Front Genet; 2023; 14():1163392. PubMed ID: 37252668
[No Abstract] [Full Text] [Related]
10. Engineering nanolayered particles for modular drug delivery.
Correa S; Dreaden EC; Gu L; Hammond PT
J Control Release; 2016 Oct; 240():364-386. PubMed ID: 26809005
[TBL] [Abstract][Full Text] [Related]
11. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
12. R&D in micro-nano-bio systems and contribution to pHealth.
Lymberis A
Stud Health Technol Inform; 2012; 177():26-38. PubMed ID: 22942027
[TBL] [Abstract][Full Text] [Related]
13. Nanobiotechnology and personalized medicine.
Jain KK
Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
[TBL] [Abstract][Full Text] [Related]
14. Responsible healthcare innovation: anticipatory governance of nanodiagnostics for theranostics medicine.
Fisher E; Boenink M; van der Burg S; Woodbury N
Expert Rev Mol Diagn; 2012 Nov; 12(8):857-70. PubMed ID: 23249203
[TBL] [Abstract][Full Text] [Related]
15. Steering vaccinomics innovations with anticipatory governance and participatory foresight.
Ozdemir V; Faraj SA; Knoppers BM
OMICS; 2011 Sep; 15(9):637-46. PubMed ID: 21848419
[TBL] [Abstract][Full Text] [Related]
16. Theranostics in primary care: pharmacogenomics tests and beyond.
Bartlett G; Antoun J; Zgheib NK
Expert Rev Mol Diagn; 2012 Nov; 12(8):841-55. PubMed ID: 23249202
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
